• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肿瘤坏死因子α阻断剂所致不良事件的管理]

[Management of adverse events induced by TNFalpha blocking agents].

作者信息

Chappuis S, Ribi C, Spertini F

机构信息

Service d'immunologie et allergie, CHUV, 1011 Lausanne.

出版信息

Rev Med Suisse. 2013 Jan 9;9(368):12-6.

PMID:23367697
Abstract

TNFalpha blocking agents are effective and essential tools in the management of many inflammatory conditions including rheumatoid arthritis, spondylarthropathies and chronic inflammatory bowel disease. With time, some known side-effects have gained in importance and others have appeared. This article focuses on the potential risks of infection and autoimmunity induced by TNFalpha blocking agents and on the strategy to prevent and treat such adverse events.

摘要

肿瘤坏死因子α阻断剂是治疗多种炎症性疾病(包括类风湿性关节炎、脊柱关节病和慢性炎症性肠病)的有效且重要的工具。随着时间的推移,一些已知的副作用变得更加突出,另一些则出现了。本文重点关注肿瘤坏死因子α阻断剂引起的感染和自身免疫的潜在风险,以及预防和治疗此类不良事件的策略。

相似文献

1
[Management of adverse events induced by TNFalpha blocking agents].[肿瘤坏死因子α阻断剂所致不良事件的管理]
Rev Med Suisse. 2013 Jan 9;9(368):12-6.
2
[Anti-cytokines in the treatment of inflammation].[抗细胞因子在炎症治疗中的应用]
Rev Prat. 2003 Mar 1;53(5):507-11.
3
Managing risks of TNF inhibitors: an update for the internist.肿瘤坏死因子抑制剂的风险管控:内科医生须知
Cleve Clin J Med. 2014 Feb;81(2):115-27. doi: 10.3949/ccjm.81a.12121.
4
Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety.肿瘤坏死因子抑制剂治疗的类风湿关节炎患者严重感染的发生率和危险因素:来自日本类风湿关节炎患者长期安全性登记处的报告。
J Rheumatol. 2011 Jul;38(7):1258-64. doi: 10.3899/jrheum.101009. Epub 2011 Apr 15.
5
Does anti-tumor necrosis factor-α therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis?: a review of longterm data.抗肿瘤坏死因子-α 治疗是否会影响类风湿关节炎患者严重感染和癌症的风险?:长期数据回顾。
J Rheumatol. 2011 Aug;38(8):1552-62. doi: 10.3899/jrheum.100995. Epub 2011 May 15.
6
[TNFalpha inhibitors for the treatment of rheumatoid arthritis].用于治疗类风湿性关节炎的肿瘤坏死因子α抑制剂
Ann Med Interne (Paris). 2002 Feb;153(1):34-40.
7
Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.一名接受英夫利昔单抗治疗类风湿性关节炎的患者出现了新发银屑病。
Dermatol Online J. 2008 Sep 15;14(9):12.
8
Do antitumor necrosis factor agents increase the risk of postoperative orthopedic infections?抗肿瘤坏死因子药物会增加骨科术后感染的风险吗?
Curr Opin Rheumatol. 2008 Jul;20(4):450-6. doi: 10.1097/BOR.0b013e3282fcc345.
9
TNF-alpha antagonism and cancer risk in rheumatoid arthritis: is continued vigilance warranted?肿瘤坏死因子-α拮抗剂与类风湿关节炎患者的癌症风险:是否需要持续保持警惕?
Discov Med. 2012 Mar;13(70):229-34.
10
Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.单核细胞增生李斯特菌感染作为肿瘤坏死因子α中和剂治疗的并发症。
Arthritis Rheum. 2003 Feb;48(2):319-24. doi: 10.1002/art.10758.

引用本文的文献

1
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors.一种新型噬菌体文库筛选肽抑制人 TNF-α 与其受体结合。
Molecules. 2014 Jun 3;19(6):7255-68. doi: 10.3390/molecules19067255.